• Douglas R Galasko, University of California, San Diego
  • Todd E Golde, University of Florida
  • Philip Scheltens, VU University Medical Center

Society Affiliations


Affiliated to Alzheimer's Disease International (ADI), London, United Kingdom

Alzheimer's Disease International is the international federation of national Alzheimer organisations and global voice for dementia, leading and unifying the dementia community to provide global solutions to a global epidemic.


There has been an error retrieving the data. Please try again.
  • Clinical characteristics of dementia with Lewy bodies

    Donaghy and McKeith review the pathology of Lewy body disease and the clinical presentation of prodromal dementia with Lewy bodies (DLB), discussing how this relates to potential biomarkers of prodromal DLB.

    Alzheimer's Research & Therapy 2014, 6:46
  • Protective effect of galantamine on brain atrophy rate

    Acetylcholinesterase inhibitor galantamine lowered the rate of whole brain atrophy, but not hippocampal atrophy, in mild cognitive impairment patients that carried the ε4 allele of apolipoprotein E only.

    Alzheimer's Research & Therapy 2014, 6:47
  • An underlying mechanism of early death in AD

    Cerebral inflammation, and not amyloid or tau pathology, is an independent risk factor for early death in Alzheimer’s disease (AD), which has implications for future clinical trials of disease-modifying therapies.

    Alzheimer's Research & Therapy 2014, 6:41
  • Basic to translational research in dementia

    A meeting report from the Alzheimer’s Research UK annual conference, held in March 2014, provides an overview of current international dementia research from fundamental disease mechanisms to clinical studies.

    Alzheimer's Research & Therapy 2014, 6:40
  • Failure for Alzheimer's drug development

    Over the past decade, 99.6% of drugs entering the Alzheimer’s disease drug development pipeline have failed and the number of clinical trials has been declining since the 2008 to 2009 period.

    Alzheimer's Research & Therapy 2014, 6:37
  • Scale for diagnosing Alzheimer's disease

    A new diagnostic scale based on cerebrospinal fluid (CSF) biomarkers can help the interpretation of CSF multivariate data to identify probabilities of patients with cognitive impairments developing Alzheimer’s disease pathology.

    Alzheimer's Research & Therapy 2014, 6:38
  • Widespread use of cardiovascular drugs

    A nationwide study of 19, 743 dementia patients in the Swedish Dementia Registry showed that cardiovascular medication is used extensively across all dementia disorders, particularly in vascular and mixed dementias.

    Alzheimer's Research & Therapy 2014, 6:34
  • Brain haemorrhage links to AD

    Martinez-Ramirez and colleagues review the pathophysiology and clinical implications of cerebral microbleeds and the link with cognitive impairment and Alzheimer's disease (AD).

    Alzheimer's Research & Therapy 2014, 6:33

Latest free review

The following review has recently become free to access:


What boxing tells us about repetitive head trauma and the brain

Charles Bernick, Sarah Banks

Alzheimer's Research & Therapy 2013, 5:23 (4 June 2013)



View more comments

Traumatic brain injury
Immuno Therapy
Alzheimer's Research & Therapy on Twitter
Alzres Manuscript

Aims & scope

Alzheimer's Research & Therapy is the major forum for translational research into Alzheimer's disease. An international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. The journal also provides reviews, viewpoints, commentaries, debates and reports. Although the primary focus is Alzheimer's dementia, the scope encompasses translational research into other neurodegenerative diseases.

Latest issue

Alzheimer's Research & Therapy Volume 6 Issue 3

The complete issue of Alzheimer's Research & Therapy Volume 6 Issue 3 is now available.

Article collections

View all article collections


The evolving field of traumatic brain injury

What do we currently know about chronic traumatic encephalopathy (CTE) and what are the most important questions in the field? Listen to a free podcast discussing this and more, as part of our special series on Traumatic Brain Injury.

Searching for biomarkers

As part of our special series on Peripheral Biomarkers, listen to a free podcast by Douglas Galasko about the advances and current issues in the search to identify blood biomarkers for Alzheimer's disease.

Submit a manuscript Sign up for article alerts Contact us

Email updates

Receive periodic news and updates relating to this journal straight to your inbox.

Indexed by

  • CAS
  • DOAJ
  • Embase
  • Journal Citation Reports/Science Edition
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • Scopus

View all

ISSN: 1758-9193